Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T19:57:37.849Z Has data issue: false hasContentIssue false

Antimicrobials and BRD

Published online by Cambridge University Press:  15 December 2009

Mike Apley*
Affiliation:
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA

Abstract

Pharmacodynamics is limited with respect to its ability to provide precise predictions to guide therapy because of complications related to the bound versus unbound state of the agent, tissue versus plasma concentrations, drug degradation over time, variations among microorganisms, and factors associated with the specific environment at the infection site. Antimicrobial susceptibility testing is likewise imprecise when applied to an individual animal; however, it is valuable on an animal population basis.

Type
Review Article
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

CLSI Publication M31-A3 – Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard – Third Edition. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087–1898, USA. Available online at webstore.ansi.orgGoogle Scholar
CLSI Publication M37-A3 – Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline – Third Edition. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087–1898, USA. Available online at webstore.ansi.orgGoogle Scholar